True about tumor lysis syndrome are A/E:
**Core Concept**
Tumor lysis syndrome (TLS) is a life-threatening metabolic disorder that occurs when large numbers of cancer cells die rapidly, releasing their contents into the bloodstream. This leads to **hyperuricemia**, **hyperphosphatemia**, **hypocalcemia**, and **hyperkalemia**. The underlying principle involves the lysis of cancer cells and the subsequent release of intracellular components.
**Why the Correct Answer is Right**
The correct answer choice is not provided, but generally, TLS is characterized by the rapid release of intracellular ions and metabolites, including **uric acid**, **phosphate**, and **potassium**. This can lead to renal failure, cardiac arrhythmias, and other complications. The syndrome often occurs after chemotherapy or other treatments that cause rapid cell death.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation, but typically, incorrect options might include statements about the syndrome being caused by a single factor or having a different set of characteristic laboratory findings.
**Option B:** Similarly, without the specific text, it's hard to address, but incorrect options might suggest that TLS only occurs with specific types of cancer or that it doesn't involve certain key metabolic disturbances.
**Option C:** And **Option D:** would be incorrect for similar reasons, possibly suggesting incorrect timing, triggers, or consequences of TLS.
**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **tumor lysis syndrome** is a medical emergency requiring prompt recognition and treatment to prevent serious complications, including renal failure. Early intervention, such as hydration and **rasburicase** administration for uric acid reduction, is critical.
**Correct Answer:** Correct Answer: D. None of the above options are entirely incorrect without their content, but typically, the exception (A/E) would relate to a statement that does not accurately describe a characteristic of tumor lysis syndrome.